Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN396827 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Legumain (LGMN) (AA 1-434) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-434
- Isotype
- IgG
- Antibody clone number
- M1
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Defining the human deubiquitinating enzyme interaction landscape.
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis.
Toward a confocal subcellular atlas of the human proteome.
Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase.
Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.
Sowa ME, Bennett EJ, Gygi SP, Harper JW
Cell 2009 Jul 23;138(2):389-403
Cell 2009 Jul 23;138(2):389-403
Expression of the cysteine protease legumain in vascular lesions and functional implications in atherogenesis.
Clerin V, Shih HH, Deng N, Hebert G, Resmini C, Shields KM, Feldman JL, Winkler A, Albert L, Maganti V, Wong A, Paulsen JE, Keith JC Jr, Vlasuk GP, Pittman DD
Atherosclerosis 2008 Nov;201(1):53-66
Atherosclerosis 2008 Nov;201(1):53-66
Toward a confocal subcellular atlas of the human proteome.
Barbe L, Lundberg E, Oksvold P, Stenius A, Lewin E, Björling E, Asplund A, Pontén F, Brismar H, Uhlén M, Andersson-Svahn H
Molecular & cellular proteomics : MCP 2008 Mar;7(3):499-508
Molecular & cellular proteomics : MCP 2008 Mar;7(3):499-508
Neuroprotective actions of PIKE-L by inhibition of SET proteolytic degradation by asparagine endopeptidase.
Liu Z, Jang SW, Liu X, Cheng D, Peng J, Yepes M, Li XJ, Matthews S, Watts C, Asano M, Hara-Nishimura I, Luo HR, Ye K
Molecular cell 2008 Mar 28;29(6):665-78
Molecular cell 2008 Mar 28;29(6):665-78
Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.
Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S
Genome research 2006 Jan;16(1):55-65
Genome research 2006 Jan;16(1):55-65
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA